JPM Brand Name


Generic Name

Ciprofloxacin Hydrochloride




The treatment of bone and joint infections, lower respiratory tract infections, bacterial exacerbations of bronchitis, skin and soft tissue infections, bacterial prostatitis, and complicated and uncomplicated urinary tract infections, including cystitis, caused by susceptible micro organisms.

The treatment of infectious diarrhea caused by enterotoxigenic strains of Campylobacter jejuni, E. coli, S. boydii, S. dysenteriae, S. flexneri, or S. sonnei.

The treatment of complicated intra-abdominal infections caused by Bacteroides fragilis, E. coli, K. pneumoniae, P. mirabilis, or P. aeruginosa, in combination with Metronidazole.

The treatment of acute sinusitis caused by H. influenzae, M. catarrhalis, or S. pneumoniae.

The treatment of typhoid fever caused by susceptible strains of Salmonella typhi.

The treatment of endocervical and urethral gonorrheal infections caused by Neisseria gonorrhoeae.

Treatment of inhalational anthrax: BACTALL is indicated to reduce the incidence or progression of the disease following exposure to aerosolized Bacillus anthracis

BACTALL is used in the treatment of chancroid caused by Haemophilus ducreyi, and in the treatment of asymptomatic carriers of Neisseria meningitidis for the elimination of meningococci from the nasopharynx.

BACTALL is also used in patients with cystic fibrosis for the treatment of pulmonary exacerbations caused by susceptible P. aeruginosa, alone or in combination with other antibacterial agents.

Note: Not all species or strains of a particular microorganism may be susceptible to BACTALL.